126 related articles for article (PubMed ID: 34454837)
1. [Patient selection and early tolerance of whole breast irradiation according to the "Fast Forward" protocol: Preliminary results].
Chaffai I; Cao K; Kissel M; El Ayachy R; Aboudaram A; Fourquet A; Kirova Y
Cancer Radiother; 2022 Jun; 26(4):542-546. PubMed ID: 34454837
[TBL] [Abstract][Full Text] [Related]
2. Whole breast radiotherapy in the isocentric lateral decubitus position: Role of the immobilization device and table on clinical results.
Krhili S; Costa E; Xu HP; Kirova YM
Cancer Radiother; 2019 Jun; 23(3):209-215. PubMed ID: 31053514
[TBL] [Abstract][Full Text] [Related]
3. [Extreme hypofractionation: New indications for breast cancer radiotherapy].
Bockel S; Louvel G; Brion T; Ung M; Berthelot K; Villaret F; Auzac G; Milewski C; Rivera S
Cancer Radiother; 2021 Oct; 25(6-7):679-683. PubMed ID: 34452822
[TBL] [Abstract][Full Text] [Related]
4. Hypofractionated radiation therapy for invasive breast cancer: From moderate to extreme protocols.
Rivera S; Hannoun-Lévi JM
Cancer Radiother; 2019 Dec; 23(8):874-882. PubMed ID: 31611051
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.
Yu E; Huang D; Leonard K; Dipetrillo T; Wazer D; Hepel J
Clin Breast Cancer; 2017 Dec; 17(8):638-643. PubMed ID: 28629952
[TBL] [Abstract][Full Text] [Related]
6. Hypofractionated whole breast radiotherapy with or without hypofractionated boost in early stage breast cancer patients: a mono-institutional analysis of skin and subcutaneous toxicity.
Palumbo I; Mariucci C; Falcinelli L; Perrucci E; Lancellotta V; Podlesko AM; Marcantonini M; Saldi S; Bini V; Aristei C
Breast Cancer; 2019 May; 26(3):290-304. PubMed ID: 30341747
[TBL] [Abstract][Full Text] [Related]
7. Patterns of locoregional failure in women with early-stage breast cancer treated by whole breast irradiation in the lateral isocentric decubitus position: Large-scale single-centre experience.
Xu HP; Bronsart E; Costa É; Krhili S; Logerot C; Bazire L; Fournier-Bidoz N; Belshi A; Fourquet A; Kirova YM
Cancer Radiother; 2019 Apr; 23(2):116-124. PubMed ID: 30935887
[TBL] [Abstract][Full Text] [Related]
8. Whole breast radiotherapy in the lateral isocentric lateral decubitus position: Long-term efficacy and toxicity results.
Bronsart E; Dureau S; Xu HP; Bazire L; Chilles A; Costa E; Logerot C; Falcou MC; Campana F; Berger F; Fourquet A; Kirova YM
Radiother Oncol; 2017 Aug; 124(2):214-219. PubMed ID: 28734546
[TBL] [Abstract][Full Text] [Related]
9. Hypofractionated irradiation of infra-supraclavicular lymph nodes after axillary dissection in patients with breast cancer post-conservative surgery: impact on late toxicity.
Guenzi M; Blandino G; Vidili MG; Aloi D; Configliacco E; Verzanini E; Tornari E; Cavagnetto F; Corvò R
Radiat Oncol; 2015 Aug; 10():177. PubMed ID: 26289040
[TBL] [Abstract][Full Text] [Related]
10. Whole breast radiotherapy in the lateral decubitus position: a dosimetric and clinical solution to decrease the doses to the organs at risk (OAR).
Kirova YM; Hijal T; Campana F; Fournier-Bidoz N; Stilhart A; Dendale R; Fourquet A
Radiother Oncol; 2014 Mar; 110(3):477-81. PubMed ID: 24342456
[TBL] [Abstract][Full Text] [Related]
11. VMAT partial-breast irradiation: acute toxicity of hypofractionated schedules of 30 Gy in five daily fractions.
La Rocca E; Lozza L; D' Ippolito E; Dispinzieri M; Giandini C; Bonfantini F; Valdagni R; Folli S; Pignoli E; Di Cosimo S; De Santis MC
Clin Transl Oncol; 2020 Oct; 22(10):1802-1808. PubMed ID: 32128672
[TBL] [Abstract][Full Text] [Related]
12. Moderate hypofractionation remains the standard of care for whole-breast radiotherapy in breast cancer: Considerations regarding FAST and FAST-Forward.
Krug D; Baumann R; Combs SE; Duma MN; Dunst J; Feyer P; Fietkau R; Haase W; Harms W; Hehr T; Piroth MD; Sedlmayer F; Souchon R; Strnad V; Budach W;
Strahlenther Onkol; 2021 Apr; 197(4):269-280. PubMed ID: 33507331
[TBL] [Abstract][Full Text] [Related]
13. Acute radiation-induced skin toxicity in hypofractionated vs. conventional whole-breast irradiation: An objective, randomized multicenter assessment using spectrophotometry.
Schmeel LC; Koch D; Schmeel FC; Röhner F; Schoroth F; Bücheler BM; Mahlmann B; Leitzen C; Schüller H; Tschirner S; Fuhrmann A; Heimann M; Brüser D; Abramian AV; Müdder T; Garbe S; Vornholt S; Schild HH; Baumert BG; Wilhelm-Buchstab TM
Radiother Oncol; 2020 May; 146():172-179. PubMed ID: 32171945
[TBL] [Abstract][Full Text] [Related]
14. Hypofractionated radiotherapy for breast cancers--preliminary results from a tertiary care center in eastern India.
Nandi M; Mahata A; Mallick I; Achari R; Chatterjee S
Asian Pac J Cancer Prev; 2014; 15(6):2505-10. PubMed ID: 24761855
[TBL] [Abstract][Full Text] [Related]
15. [Concurrent radiation therapy and dual HER2 blockade in breast cancer: Assessment of toxicity].
Ben Dhia S; Loap P; Loirat D; Vincent-Salomon A; Cao K; Escalup L; Fourquet A; Kirova Y
Cancer Radiother; 2021 Jul; 25(5):424-431. PubMed ID: 33771453
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing acute and late toxicity in the era of adjuvant hypofractionated breast radiotherapy.
De Santis MC; Bonfantini F; Di Salvo F; Dispinzieri M; Mantero E; Soncini F; Baili P; Sant M; Bianchi G; Maggi C; Di Cosimo S; Agresti R; Pignoli E; Valdagni R; Lozza L
Breast; 2016 Oct; 29():90-5. PubMed ID: 27476083
[TBL] [Abstract][Full Text] [Related]
17. Evaluating Candidacy for Hypofractionated Radiation Therapy, Accelerated Partial Breast Irradiation, and Endocrine Therapy After Breast Conserving Surgery: A Surveillance Epidemiology and End Results (SEER) Analysis.
Manyam BV; Tendulkar R; Cherian S; Vicini F; Badiyan SN; Shah C
Am J Clin Oncol; 2018 Jun; 41(6):526-531. PubMed ID: 27635622
[TBL] [Abstract][Full Text] [Related]
18. A phase 2 trial of once-weekly hypofractionated breast irradiation: first report of acute toxicity, feasibility, and patient satisfaction.
Dragun AE; Quillo AR; Riley EC; Roberts TL; Hunter AM; Rai SN; Callender GG; Jain D; McMasters KM; Spanos WJ
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):e123-8. PubMed ID: 23195779
[TBL] [Abstract][Full Text] [Related]
19. A Phase 2 Study of 2 Weeks of Adjuvant Whole Breast/Chest Wall and/or Regional Nodal Radiation Therapy for Patients With Breast Cancer.
Yadav BS; Sharma SC
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):874-881. PubMed ID: 29485066
[TBL] [Abstract][Full Text] [Related]
20. Final Analysis of a Phase 2 Trial of Once Weekly Hypofractionated Whole Breast Irradiation for Early-Stage Breast Cancer.
Reshko LB; Pan J; Rai SN; Ajkay N; Dragun A; Roberts TL; Riley EC; Quillo AR; Scoggins CR; McMasters KM; Eldredge-Hindy H
Int J Radiat Oncol Biol Phys; 2022 Jan; 112(1):56-65. PubMed ID: 34710520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
